Effectiveness and costs of atypical versus typical antipsychotic treatment for schizophrenia in routine care

被引：0
|
作者：
Stargardt, T.
Weinbrenner, S.
Busse, R.
Juckel, G.
Gericke, C. A.
机构：
[1] Berlin Univ Technol, Berlin, Germany
[2] Ruhr Univ Bochum, Sch Med, D-4630 Bochum, Germany
[3] Univ Adelaide, Adelaide, SA, Australia
来源：
VALUE IN HEALTH | 2006年 / 9卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)63183-X
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A196 / A196
页数：1
相关论文
共 50 条
  • [1] Effectiveness and cost of atypical versus typical antipsychotic treatment for schizophrenia in routine care
    Stargardt, Tom
    Weinbrenner, Susanne
    Busse, Reinhard
    Juckel, Georg
    Gericke, Christian A.
    JOURNAL OF MENTAL HEALTH POLICY AND ECONOMICS, 2008, 11 (02): : 89 - 97
  • [2] Effectiveness and Cost of Atypical Versus Typical Antipsychotic Treatment in a Nationwide Cohort of Patients With Schizophrenia in Germany
    Stargardt, Tom
    Edel, Marc-Andreas
    Ebert, Andreas
    Busse, Reinhard
    Juckel, Georg
    Gericke, Christian A.
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2012, 32 (05) : 602 - 607
  • [3] The effectiveness of the atypical antipsychotic aripiprazole versus standard of care treatment in patients with schizophrenia: The star study
    Kerwin, R.
    L'Italien, G.
    Hanssens, L.
    Marcus, R. N.
    McQuade, R.
    Carson, W. H.
    Bewen, J. -N.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S283 - S283
  • [4] Prevalence of hyperprolactinemia in schizophrenia: Association with typical and atypical antipsychotic treatment
    Montgomery, J
    Winterbottom, E
    Jessani, M
    Kohegyi, E
    Fulmer, J
    Seamonds, B
    Josiassen, RC
    JOURNAL OF CLINICAL PSYCHIATRY, 2004, 65 (11) : 1491 - 1498
  • [5] Atypical versus typical antipsychotic treatment prognosis based on VEPs and WCST scores in paranoid schizophrenia
    Mazurek, I
    Loza, B
    Lecyk, A
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 : S347 - S348
  • [6] Typical and atypical antipsychotic use and relapses in schizophrenia
    Cáceres, M. C.
    Peñas-Lledó, E. M.
    Dorado, P.
    de la Rubia, A.
    González, I.
    Gutierrez, J. R.
    LLerena, A.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2006, 99 : 34 - 35
  • [7] Safety and effectiveness of olanzapine versus typical antipsychotic drugs in the treatment of inpatients with schizophrenia (EUROPA study)
    Gomez, JC
    Sacristan, JA
    Carrasco, PR
    Alvarez, E
    Bobes, J
    Cañas, F
    Gascon, J
    Gibert, J
    Gutierrez, M
    EUROPEAN PSYCHIATRY, 2000, 15 : 409S - 409S
  • [8] Hormonal side effects in women: Typical versus atypical antipsychotic treatment
    Dickson, RA
    Seeman, MV
    Corenblum, B
    JOURNAL OF CLINICAL PSYCHIATRY, 2000, 61 : 10 - 15
  • [9] Effectiveness and onset of action of olanzapine versus typical antipsychotic drugs in the treatment of inpatients with schizophrenia (Europa study)
    Alvarez, E
    Gómez, J
    Sacristan, JA
    Bobes, J
    Cañas, F
    Carrasco, JL
    Gascón, J
    SCHIZOPHRENIA RESEARCH, 2001, 49 (1-2) : 219 - 219
  • [10] Onset of action and effectiveness with olanzapine versus typical antipsychotic drugs in the treatment of inpatients with schizophrenia (EUROPA Study)
    Gutierrez, M
    Ciudad, A
    Alvarez, E
    Bobes, J
    Cañas, F
    Carrasco, JL
    Gascon, J
    Gibert, J
    Gómez, JC
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S52 - S52
12345